Shlomo ...ith Bloomberg's Deirdre Bolton in New York about Teva's agreement to buy Barr for $7.46 billion, the outlook for the integration of the companies and Teva's growth strategy. (Source: ...

4

Generic drug giant Teva Pharmaceuticals bought rival Barr for $7 billion, and some analysts say this could spark a big wave of consolidation. CNBCs Mike Huckman has the details.

...buy Barr Pharmaceuticals Inc. Teva, the world's biggest maker of generic drugs agreed to buy rival Barr for $7.46 billion to expand into new markets and widen its lead in copying brand-name ...

805

Joint Interview with Teva CEO Shlomo Yanai and Barr CEO Bruce Downey

49

Joint Interview with Teva CEO Shlomo Yanai and Barr CEO Bruce Downey